KYMR Stock Posts

11/9/2026 1:07:30 PM

Unusual Option Volume

KYMR Kymera Therapeutics135.99+4.26 (+3.2%)

Kymera Therapeutics trades 2,238 contracts.

6/26/2026 2:52:10 PM

Unusual Option Volume

KYMR Kymera Therapeutics108.38-8.08 (-6.9%)

Kymera Therapeutics trades 2,580 contracts.

6/25/2026 10:48:42 AM

Unusual Option Volume

KYMR Kymera Therapeutics121.50+21.63 (+21.7%)

12/9/2025 1:45:46 AM

KYMR #KymeraTherapeutics stock declines -3.8% in after hours trading. See the latest news.

After Hours Decliner

KYMR Kymera Therapeutics94.30+27.68+41.6%

After Hours:90.70-3.60 (-3.8%)

Globe NewswireMon, 8-Dec 4:01 PM

12/8/2025 8:13:00 PM

KYMR #KymeraTherapeutics stock declines -3.8% in after hours trading. See the latest news.

After Hours Decliner

KYMR Kymera Therapeutics94.30+27.68+41.6%

After Hours:90.70-3.60 (-3.8%)

Globe NewswireMon, 8-Dec 4:01 PM

12/8/2025 2:30:06 PM

Unusual Option Volume

KYMR Kymera Therapeutics94.75+28.13 (+42.2%)

Kymera Therapeutics trades 2,215 contracts. The company has the following event: KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results Video Conference Call and Webcast on Dec 8, 2025. News: Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic Dermatitis

Load Earlier Posts

Market Data Delayed 15 Minutes